Unmet Need in Relapsed/Refractory (RR) Mantle Cell Lymphoma (MCL) Post-Bruton Tyrosine Kinase Inhibitor (BTKi): Systematic Literature Review and Meta-Analysis
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
关键词
MCL,relapsed/refractory,survival,brexucabtagene autoleucel,CAR T-cell therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要